Old West Investment Management’s Akebia Therapeutics AKBA Stock Holding History

Old West Investment Management’s Portfolio AKBA Stock Details AKBA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-50,074	Closed	-$680K	–	58
2020 Q2	$680K	Sell	50,074 -164	-0.3%	-$1.7K	0.2%	38
2020 Q1	$380K	Sell	50,238 -5,487	-10%	-$42.7K	0.29%	43
2019 Q4	$352K	Sell	55,725 -93,894	-63%	-$446K	0.13%	57
2019 Q3	$586K	Sell	149,619 -218,251	-59%	-$935K	0.34%	46
2019 Q2	$1.78M	Sell	367,870 -9,850	-3%	-$56K	0.84%	34
2019 Q1	$3.09M	Sell	377,720 -81,737	-18%	-$561K	1.12%	17
2018 Q4	$2.54M	Buy	+459,457	New	+$3.6M	0.68%	25

Other funds holding AKBA

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Old West Investment Management's AKBA Position: Q3 2020 in Review

Old West Investment Management sold out of Akebia Therapeutics (AKBA) in Q3 2020, closing a stake of 50,074 shares — an estimated $680K sold.

Old West Investment Management first reported a position in AKBA in Q4 2018 and held it in 7 quarters. The position peaked at $3.09M in Q1 2019. 164 funds tracked by Wall St. Rank hold AKBA as of Q3 2020.

Old West Investment Management reported no remaining Akebia Therapeutics position as of Q3 2020 after selling out during the quarter.
Old West Investment Management sold 50,074 Akebia Therapeutics shares in Q3 2020, an estimated $680K.
Old West Investment Management first reported a position in Akebia Therapeutics in Q4 2018 and held it in 7 quarters.
Old West Investment Management's Akebia Therapeutics position peaked at $3.09M in Q1 2019.
164 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q3 2020.

Based on Old West Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.